Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
0.9837
+0.0926 (10.39%)
Sep 16, 2026, 1:54 PM EDT - Market open
Nautilus Biotechnology Employees
Nautilus Biotechnology had 127 employees as of June 30, 2026. The number of employees decreased by 1 or -0.78% compared to the same quarter last year.
Employees
127
Change
-1
Growth
-0.78%
Revenue / Employee
$1,496
Profits / Employee
-$445,047
Market Cap
125.18M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 127 | -1 | -0.78% |
| Mar 31, 2026 | 127 | -7 | -5.22% |
| Dec 31, 2025 | 130 | -25 | -16.13% |
| Sep 30, 2025 | 124 | -37 | -22.98% |
| Jun 30, 2025 | 128 | -36 | -21.95% |
| Mar 31, 2025 | 134 | -29 | -17.79% |
| Dec 31, 2024 | 155 | -12 | -7.19% |
| Sep 30, 2024 | 161 | 1 | 0.63% |
| Jun 30, 2024 | 164 | 11 | 7.19% |
| Mar 31, 2024 | 163 | 10 | 6.54% |
| Dec 31, 2023 | 167 | 33 | 24.63% |
| Sep 30, 2023 | 160 | 33 | 25.98% |
| Jun 30, 2023 | 153 | 29 | 23.39% |
| Mar 31, 2023 | 153 | 34 | 28.57% |
| Dec 31, 2022 | 134 | 21 | 18.58% |
| Sep 30, 2022 | 127 | 30 | 30.93% |
| Jun 30, 2022 | 124 | 35 | 39.33% |
| Mar 31, 2022 | 119 | 30 | 33.71% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Cibus | 118 |
| Inovio Pharmaceuticals | 112 |
| Rani Therapeutics Holdings | 71 |
| PMV Pharmaceuticals | 54 |
| OnKure Therapeutics | 45 |
| Vivani Medical | 42 |
| Aardvark Therapeutics | 28 |
| Genelux | 26 |
NAUT News
- 4 days ago - Nautilus Biotechnology files $300M mixed securities shelf - TheFly
- 5 days ago - Nautilus Biotechnology Registration statement: Registration filing - Filings
- 7 days ago - Nautilus Biotechnology initiated with an Outperform at Leerink - TheFly
- 12 days ago - Nature Methods Publication Reveals Deep Insights into Functional Biology through First-of-its-Kind Quantification of Tau Proteoforms - GlobeNewsWire
- 7 weeks ago - Nautilus Biotechnology Earnings Call Transcript: Q2 2026 - Transcripts
- 7 weeks ago - Nautilus Biotechnology Earnings release: Q2 2026 - Filings
- 7 weeks ago - Nautilus Biotechnology Quarterly report: Q2 2026 - Filings
- 7 weeks ago - Nautilus Biotechnology Reports Second Quarter 2026 Financial Results - GlobeNewsWire